Literature DB >> 11732000

Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis.

M Pozzi1, G Grassi, E Redaelli, R Dell'oro, L Ratti, A Redaelli, G Foglia, A Di Lelio, G Mancia.   

Abstract

Overactivity of the sympathetic nervous system and portal hypertension are key factors in the development of ascites in cirrhosis. The sympathoexcitation that characterizes the more advanced stages of liver diseases is less clearly defined in preascitic cirrhosis. We measured sympathetic nerve traffic to skeletal muscle (peroneal nerve) and to skin districts by microneurography in (1) 12 Child class A cirrhotic patients with clinically significant portal hypertension (portal pressure gradient > 10 mm Hg, 14.8 +/- 1.2 mm Hg, mean +/- SEM) but without actual or previous ascites, (2) 16 Child class C cirrhotic patients with tense ascites, and (3) 10 patients with mild congestive heart failure, a condition paradigmatic of a marked sympathetic activation. Muscle sympathetic nerve traffic was markedly increased in Child class C subjects as compared with controls (23.9 +/- 1.6 bursts/min, P <.01) and superimposable to that recorded in heart failure patients (52.9 +/- 4.7 vs. 60.3 +/- 2 bursts/min, P = not significant). Muscle sympathetic nerve traffic was also increased in Child class A subjects (41.6 +/- 2 bursts/min, P <.01 vs. controls) although to a lesser extent (P <.05 vs. Child class C patients). Skin sympathetic nerve traffic was within the normal range in all patients. Neurohormones were all markedly increased in Child class C subjects. Only norepinephrine was increased in Child class A patients. Our data show that sympathetic nerve traffic activation (1) is already detectable in Child class A cirrhosis when clinically significant portal hypertension is present but ascites never developed and (2) is not generalized because although muscle traffic is increased, skin traffic is within normal range. The role of drugs modulating sympathoactivation should be investigated in preascitic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11732000     DOI: 10.1053/jhep.2001.29198

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Cardiac response to exercise in cirrhosis.

Authors:  R H Wachsberg
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

Review 3.  Renal dysfunction in cirrhosis: diagnosis, treatment and prevention.

Authors:  Elaine Yeung; Elaine Yong; Florence Wong
Journal:  MedGenMed       Date:  2004-12-02

Review 4.  Measuring and quantifying skin sympathetic nervous system activity in humans.

Authors:  Jody L Greaney; W Larry Kenney
Journal:  J Neurophysiol       Date:  2017-07-12       Impact factor: 2.714

5.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

6.  Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.

Authors:  G Sansoè; F Wong
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

7.  Differential Sympathetic Vasomotor Activation Induced by Liver Cirrhosis in Rats.

Authors:  Heder F G Estrela; Elaine S Damásio; Eduardo K U N Fonseca; Cássia T Bergamaschi; Ruy R Campos
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

8.  Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.

Authors:  Manas Kumar Behera; Surendra Nath Swain; Manoj Kumar Sahu; Gaurav Kumar Behera; Debakanta Mishra; Jimmy Narayan; Ayaskant Singh; Shobhit Agarwal; Pradeep Kumar Mallick
Journal:  Int J Hepatol       Date:  2021-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.